COGNEX 30 Pill - orange yellow capsule/oblong, 15mm
Generic Name: tacrine
Pill with imprint COGNEX 30 is Orange / Yellow, Capsule/Oblong and has been identified as Cognex 30 MG. It is supplied by Sciele Pharma Inc.
Cognex is used in the treatment of Alzheimer's Disease; Dementia and belongs to the drug class cholinesterase inhibitors. Risk cannot be ruled out during pregnancy. Cognex 30 MG is not a controlled substance under the Controlled Substances Act (CSA).
Images for COGNEX 30
Cognex
- Generic Name
- tacrine
- Imprint
- COGNEX 30
- Strength
- 30 MG
- Color
- Orange / Yellow
- Size
- 15.00 mm
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Cholinesterase inhibitors
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Sciele Pharma Inc.
- National Drug Code (NDC)
- 59630-0192 (Discontinued)
See also:
Aricept
Aricept is used to treat mild to severe dementia caused by Alzheimer's disease. Learn about side ...
Namenda
Namenda is used to treat dementia associated with Alzheimer's disease. Learn about side effects ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Exelon
Exelon (rivastigmine) is used to treat dementia caused by Alzheimer's or Parkinson's disease ...
Leqembi
Leqembi (lecanemab) is used to treat Alzheimer’s disease to help slow the progression of dementia s ...
Namzaric
Namzaric (memantine/donepezil) is used to treat Alzheimer's Disease. Includes Namzaric side ...
Vitamin e
Vitamin E is an antioxidant that occurs naturally in some foods and is used to treat or prevent ...
Rivastigmine
Rivastigmine is used for alzheimer's disease, lewy body dementia, parkinson's disease
More about Cognex (tacrine)
- Check interactions
- Compare alternatives
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: cholinesterase inhibitors
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.